Curi Bio

Accelerating Discovery of Next Generation Human Medicines

[Curi Bio @Curi_Bio]

Come see @Curi_Bio's Montri Meeseepong, PhD, present “Regulatory Strategies and Commercialization of NAMs” at the 6th Pharma & Bio Industry Innovation Forum, Nov 12, 14:00–14:20.
Book time: https://t.co/FCYM3NpaKk
#NAMs #RegulatoryScience #DrugDevelopment #3DTissue #CuriBio

[Curi Bio @Curi_Bio]

From academic labs to drug discovery: join @Curi_Bio at TERMIS-AM! Nov 17, 8–9:30 AM CT | Session 43 Keynote: Nicholas Geisse, PhD Talk: Jacob Fleming, PhD, on ML-guided 3D NMJ tissues. Meet us at booth #12.
Book 1:1: https://t.co/kswAQPnlnT
#TERMIS #NAMs

[Curi Bio @Curi_Bio]

At #AHA26, Nelsa Estrella, Ph.D., shares new @Curi_Bio data from human 3D heart tissues: MYBPC3/fibrosis, PKP2 arrhythmia models and scaling to 96-well screening.
Sunday, Nov 8 | 9 AM
Book time here to learn more: https://t.co/sWQAe2LEc8
#AHAScientificSessions #CuriBio

[Curi Bio @Curi_Bio]

⚡ Electrical stimulation can bypass the NMJ. 💡 Our optogenetic motor neurons use light to drive synaptic transmission in 3D human NMJ tissues on Mantarray™ for BoNT potency testing.
Explore two lines from @Curi_Bio, available now 🔗 https://t.co/WOccKiHckU
#Optogenetics #NMJ

[Curi Bio @Curi_Bio]

Join @Curi_Bio in Seoul Nov 12 at the 6th Pharma & Bio Industry Innovation Forum to discuss NAMs and human-relevant 3D tissue models. Request a meeting with the team: https://t.co/8qf1BG4MTs
#NAMs #DrugDiscovery #3DTissue #HumanRelevant #CuriBio

[Curi Bio @Curi_Bio]

Meet @Curi_Bio at TERMIS-AM 2026 in New Orleans, Nov 15–18! Visit booth #12 to explore human-relevant 3D tissues. Hear CEO Nicholas Geisse, PhD, keynote Nov 17, Session 43. Book a meeting: https://t.co/36TSXyIJqs
#TERMIS #TissueEngineering #3DTissue #NAMs

[Curi Bio @Curi_Bio]

Join @Curi_Bio at #KPS2026 for a luncheon seminar with Nari Kim, MD, PhD, on 3D human tissue platforms for functional assays and drug discovery. Nov. 4 | 11:30 AM–12:30 PM Room A, 5F, Gachon Convention Center
Book a consult: https://t.co/WBtX5JnjWN
#NAMs #DrugDiscovery #KPS2026

[Curi Bio @Curi_Bio]

Heading to #AHA26 in Chicago? 🌭 Hear @Curi_Bio’s Nelsa Estrella, Ph.D., discuss modeling genetic cardiomyopathies and arrhythmias with human 3D engineered heart tissues on Mantarray™. Nov. 8 at 9 AM
Book time to learn more: https://t.co/KCasWYxqqv

#AHAScientificSessions

[Curi Bio @Curi_Bio]

Happy #FluorescenceFriday! 🔬
Human iPSC-derived optogenetic motor neurons from @Curi_Bio. ChR2 lets blue light trigger firing, supporting optogenetic stimulation of NMJ tissues on Mantarray™.
Learn more: https://t.co/Gi8HQlT9mR

#FluorescenceFriday #MotorNeurons #Optogenetics

[Curi Bio @Curi_Bio]

ICYMI: Explore force & Ca2+ readouts in a patient-derived BAG3-mutant DCM model w/ @Curi_Bio + Greenstone Biosciences. See how Mantarray™ & Nautilai™ inform disease in drug-response studies. 🫀
Watch on-demand: https://t.co/l1gxXQLkRT

#DrugDiscovery #CardiacDisease #iPSC

[Curi Bio @Curi_Bio]

Move from setup to human insights sooner. @Curi_Bio’s 3D Tissue Casting Kits combine ready-to-cast cells, casting plates and validated media for cardiac, skeletal muscle and NMJ research.
Explore → https://t.co/9gdujOn5bU
#3DTissue #DrugDiscovery

[Curi Bio @Curi_Bio]

Heading to #KPS2026? Meet @Curi_Bio Nov 3–5, 2026 at Gachon University in Seongnam to discuss 3D human tissue platforms and functional assays for cardiovascular, neuromuscular, and metabolic research.
Request a meeting: https://t.co/IwPX5kTGNe
#TranslationalMedicine #NAMs

[Curi Bio @Curi_Bio]

Families facing XLMTM still await disease-modifying therapies. @Curi_Bio’s patient-derived 3D muscle model recapitulates impaired force and fatigue, enabling functional studies on Mantarray™.
Explore the model → https://t.co/cAM1fCKfbC

#XLMTM #RareDisease

[Curi Bio @Curi_Bio]

Today at #APHRS2026: Dr. Nari Kim shares genetic and transient knockdown strategies for modeling cardiomyopathies and arrhythmias in human 3D EHTs. 09:18–09:30 KST | Room 08, BEXCO, Busan
Meet @Curi_Bio: 👉 https://t.co/aqXyDKqBCe

#CardiacResearch #Cardiomyopathy #CuriBio

[Curi Bio @Curi_Bio]

What can force + calcium measurements reveal about BAG3-related DCM? Join @Curi_Bio + Greenstone Biosciences next week to explore 3D human heart tissue models. Oct 28 | 8 AM PDT / 11 AM EDT / 4 PM CET
Register soon: https://t.co/HoPHu2WfxO
#iPSC #DrugDiscovery

[Curi Bio @Curi_Bio]

Go beyond contractility. @Curi_Bio’s Cardiac Fibrosis Assay uses human iPSC-derived cardiac tissue to support compound screening and mechanism-of-action studies. Available as a Curi Engine™ research service.
Explore our assay: https://t.co/afHG3Puhyq
#CardiacFibrosis

[Curi Bio @Curi_Bio]

@Curi_Bio’s NMJ Functional Potency Assay is available as a non-animal BoNT research service. FDA acceptance of our ISTAND Letter of Intent is a step toward qualification, not approval for routine QC use.
👉Explore the assay for your BoNT program: https://t.co/qyPJbpTRJB
#BoNT

[Curi Bio @Curi_Bio]

Heading to #ESGCT2026 in Hamburg? Meet #CuriBio to explore AAV capsid screening in human iPSC-derived 3D muscle tissues with functional readouts. Poster P0191 | Foyer 3 + H Wed, 28 Oct | 13:30–15:30 Book time here: https://t.co/VKAxeBpqdh

#GeneTherapy #AAV #DrugDiscovery

[Curi Bio @Curi_Bio]

Happy #FluorescenceFriday! 🔬
Calcium imaging on Nautilai™ shows slower conduction and punctate propagation sites in BAG3-mutant cardiomyocytes from @GreenstoneBio.
📄 App note: https://t.co/B1RbEhOdhm
🔗 Webinar Oct 28, 8 AM PDT: https://t.co/iryTQNqO8E

[Curi Bio @Curi_Bio]

Attend @Curi_Bio Korea’s #ICDM2026 presentations on 3D human muscle models for atrophy, insulin sensitivity & metabolism.
Oral: Oct 16 | Poster PN1-008: Oct 16–17

Meet the team to discuss your muscle research: https://t.co/nJmapDoLJe
#Diabetes #DrugDiscovery #CuriBio